FABP5 and hepatocellular carcinoma: On the other hand, FABP5 promotes cancer invasion by inducing the epithelial-to-mesenchymal (EMT) transition of hepatocellular carcinoma (HCC), and targeting FABP5 results in altered profiles of lipid signaling intermediates and decreases lipid-mediated invasion in PCa cells.61